Clinical Trial Update: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated intravenous tedisamil for rapidly converting atrial fibrillation or atrial flutter to normal sinus rhythm in female participants; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Tedisamil (tedisamil)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED